Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 51% ± 24% | |
GABAergic neuron | 7 studies | 50% ± 20% | |
astrocyte | 7 studies | 24% ± 7% | |
oligodendrocyte precursor cell | 6 studies | 23% ± 8% | |
neuron | 5 studies | 30% ± 9% | |
retina horizontal cell | 5 studies | 23% ± 6% | |
interneuron | 5 studies | 45% ± 24% | |
GABAergic interneuron | 3 studies | 29% ± 8% | |
retinal ganglion cell | 3 studies | 31% ± 11% | |
smooth muscle cell | 3 studies | 37% ± 16% | |
rod bipolar cell | 3 studies | 25% ± 3% | |
granule cell | 3 studies | 33% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 10880.54 | 2598 / 2642 | 97% | 19.89 | 683 / 705 |
adrenal gland | 100% | 16973.55 | 258 / 258 | 95% | 31.25 | 218 / 230 |
thymus | 99% | 3594.94 | 645 / 653 | 86% | 44.68 | 519 / 605 |
prostate | 91% | 2509.28 | 224 / 245 | 90% | 6.97 | 454 / 502 |
ovary | 100% | 16203.02 | 180 / 180 | 67% | 7.61 | 289 / 430 |
pancreas | 96% | 2249.28 | 316 / 328 | 44% | 2.86 | 78 / 178 |
breast | 67% | 2295.61 | 308 / 459 | 68% | 9.48 | 758 / 1118 |
uterus | 99% | 19257.19 | 168 / 170 | 17% | 3.04 | 78 / 459 |
stomach | 80% | 2543.12 | 286 / 359 | 7% | 0.77 | 21 / 286 |
esophagus | 65% | 4528.36 | 939 / 1445 | 17% | 1.21 | 32 / 183 |
heart | 82% | 2075.26 | 705 / 861 | 0% | 0 | 0 / 0 |
muscle | 78% | 1762.42 | 627 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 77% | 1666.26 | 1024 / 1335 | 0% | 0 | 0 / 0 |
bladder | 67% | 2675.29 | 14 / 21 | 8% | 0.49 | 38 / 504 |
lung | 46% | 893.59 | 265 / 578 | 28% | 1.99 | 324 / 1155 |
intestine | 65% | 2323.71 | 624 / 966 | 5% | 0.28 | 25 / 527 |
kidney | 42% | 749.03 | 37 / 89 | 14% | 0.96 | 128 / 901 |
adipose | 34% | 945.22 | 414 / 1204 | 0% | 0 | 0 / 0 |
skin | 9% | 151.33 | 158 / 1809 | 22% | 2.12 | 105 / 472 |
eye | 0% | 0 | 0 / 0 | 13% | 1.08 | 10 / 80 |
spleen | 12% | 197.77 | 28 / 241 | 0% | 0 | 0 / 0 |
liver | 2% | 33.95 | 5 / 226 | 8% | 0.47 | 33 / 406 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.34 | 2 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.19 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005737 | Cellular component | cytoplasm |
GO_0046872 | Molecular function | metal ion binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LONRF2 |
Protein name | Alternative protein LONRF2 LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192) LONRF2 protein |
Synonyms | RNF192 |
Description | |
Accessions | B7ZKY9 L8E9U6 Q1L5Z9 ENST00000409647.1 [Q1L5Z9-2] ENST00000393437.8 [Q1L5Z9-1] |